John Yingling, DO
Orthopaedic Surgery · Oklahoma City, OKNPI 1164800058
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Curvafix, Inc. accounts for 63.5% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $12,768, more than ten times the $15 reported in 2020.
Across 204 payments — averaging $176.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curvafix, Inc.$23K
- Stryker$6K
- Arthrex$3K
- Smith+Nephew$2K
- US Implant Solutions, LLC$2K
- Acera Surgical, Inc.$455
- plus $857 from 9 others
What the payments were for
- Speaking & faculty fees$21,33959%
- Travel & lodging$3,56310%
- Food & beverage$8,79524%
- Education$2,4007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curvafix, Inc. | 12 | $22,923 |
| Stryker | 98 | $5,608 |
| Arthrex | 12 | $2,916 |
| Smith+Nephew | 45 | $1,748 |
| US Implant Solutions, LLC | 8 | $1,591 |
| Acera Surgical, Inc. | 12 | $455 |
| Pylant Medical | 6 | $342 |
| Onkos Surgical, Inc. | 1 | $150 |
| Johnson & Johnson | 3 | $139 |
| Acumed LLC | 2 | $84 |
| Illuminoss Medical, Inc. | 1 | $50 |
| Kerecis Limited | 1 | $49 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CurvaFix IM Implant$22,826
- PRO$1,191
- AXSOS$655
- T2 ALPHA$624
- T2$537
- VARIAX$500
- TRIGEN InterTAN$406
- GAMMA$318
- Restrata Wound Matrix$284
- HOFFMANN$279
- EVOS$268
- AUTOFIX$155
- MAKO$155
- ELEOS LIMB SALVAGE SYSTEM$150
- ADAPT$126
- TFN-Advance$116
How this compares
$36,097 in reported general payments places this provider in the 85th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $283 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $141 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oklahoma City
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Ronald DumiganOklahoma City$169K
- Paul MaitinoOklahoma City$110K
- Thomas TkachOklahoma City$83K
- Brian LevingsOklahoma City$80K
- Christopher WhiteOklahoma City$73K
- Raymond SteinmetzOklahoma City$64K
- Michael JohnsonOklahoma City$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.